Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccination in donor egg IVF recipients
NCT02946177Phase 4Unknown
- Sponsor
- Center for Human Reproduction
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of influenza vaccine in infertility and recurrent miscarriage (RPL) (2 arms), sponsored by Center for Human Reproduction. Primary endpoint: Clinical Pregnancy Rate at 8 weeks. Status: unknown.
02
Drugs
influenza vaccine
03
Conditions
infertilityrecurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT02946177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946177.